Omnicell, Inc. OMCL

Company Overview

Omnicell, Inc. is a healthcare technology and automation company focused on medication management solutions for hospitals, health systems, post-acute care facilities, and pharmacies. The company operates primarily within the healthcare technology, pharmacy automation, and medication adherence industries. Omnicell’s core offerings include automated dispensing systems, medication management software, pharmacy robotics, intravenous compounding technologies, specialty pharmacy services, and analytics platforms designed to improve medication safety, operational efficiency, and regulatory compliance across healthcare environments.

The company’s primary revenue drivers include sales and servicing of automated medication dispensing systems, subscription-based software and cloud platforms, consumable products, and pharmacy-related services. Omnicell serves acute care hospitals, health systems, retail and specialty pharmacies, and long-term care providers primarily in the United States, while also maintaining operations in selected international markets. A major component of the company’s strategic positioning is its “Autonomous Pharmacy” vision, which integrates software, robotics, and data analytics to automate medication workflows across care settings. Founded in 1992, Omnicell expanded from automated dispensing cabinets into broader pharmacy automation and software solutions through internal development and acquisitions, including the acquisitions of Aesynt, Talyst, and ReCept Holdings.